Trial intelligence / Profile preview

Tongli enteric-coated capsule for functional constipation (excess-heat pattern)

CTR20200616Phase 2Completed

Sponsor
Beijing Incuris Biological Products Research Institute
Start
Aug 2023
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Countries
1
01

Overview

A Phase 2 trial of bifidobacterium infantis CURE 21 in functional constipation (FC), sponsored by Beijing Incuris Biological Products Research Institute. Started Aug 2023; status: completed.

02

Drugs

bifidobacterium infantis CURE 21
03

Conditions

functional constipation (FC)

Beyond the preview

Go deeper on CTR20200616.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20200616.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call